Radial Soundwave for Sesamoidopathy in Athletes: A Pilot Study

• Published in: The Journal of foot and ankle surgery 2016-11, Vol.55 (6), p.1333-1335
• Main Authors: Saxena, Amol, DPM, FACFAS, Yun, Andrew, DPM, Patel, Rajan, DPM, Gerdesmeyer, Ludger, MD, PhD, Maffulli, Nicola, MD, MS, PhD, FRCS(Orth)
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Athletic Injuries - therapy; avascular necrosis; bipartite sesamoid; Child; Female; Humans; Joint Diseases - therapy; Male; Metatarsophalangeal Joint; Middle Aged; Orthopedics; Pain Measurement; Pilot Projects; Sesamoid Bones; sesamoidectomy; sesamoiditis; Treatment Outcome; Ultrasonic Therapy - methods; Young Adult
• ISSN: 1067-2516; 1542-2224
• DOI: 10.1053/j.jfas.2016.07.024

Abstract The purpose of the present study was to evaluate the efficacy of radial soundwave therapy (RSW) for the management of sesamoiditis, symptomatic bipartite sesamoids, and avascular necrosis in athletic patients. The data from 10 patients undergoing RSW for sesamoiditis were retrospectively studied. Three treatments at 2.4 Bar and 13 Hz, for a total of 2500 pulses in each session, were administered to the affected sesamoid approximately 1 week apart. The Roles and Maudsley score and the visual analog scale (VAS) were used to assess disability and pain. An overall improvement was seen in reported pain after RSW. The pretreatment VAS score was 5.9 ± 1.7 and the post-treatment VAS score improved to 2.3 ± 2.4 ( p  = .0001). The activity pretreatment Roles and Maudsley score was 3.1 ± 0.3 and the post-treatment score was 1.5 ± 0.7 ( p  = .00003). All but 1 of the patients (90%) reported some or complete relief of pain. The mean time to return to activity was 10.1 ± 15.6 weeks, although this value was biased by 1 patient requiring 1 year to return to activity. Eliminating this patient, the average time to return to activity was 5.4 ± 5.6 weeks. Three patients in the cohort did not have to stop their desired activity at all, including 1 gymnast and 1 runner. Of these 3 patients, 2 (20% of all patients) reported complete relief of pain (VAS score of 0) after treatment. The third patient experienced a significant decrease in pain, with the VAS score, improving from 7 to 1. The results of the present study have demonstrated that RSW can be a viable treatment of certain symptomatic sesamoid pathologies and can be considered a valid alternative to surgery.